Comparison of serum lactate value with and without injection magnesium sulphate in sepsis
Phase 2
- Conditions
- Health Condition 1: R790- Abnormal level of blood mineral
- Registration Number
- CTRI/2024/07/070763
- Lead Sponsor
- Park Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Critically I’ll patients following sepsis 3 guidelines
Exclusion Criteria
Hypomagnesemia ,Chronic liver disease ,chronic kidney disease ,pregnant and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Does Administration of Intravenous Magnesium Sulphate decreases the duration of lacatate clearance in acute phase of sepsis in first 72 hoursTimepoint: first 72 hours
- Secondary Outcome Measures
Name Time Method Maintaing serum Magnesium at higher limit of Normal during acute phase of sepsis reduces SOFA score, APACHE score in acute phase of sepsis in admission ,24 hours ,48 hours & 72 hoursTimepoint: At admission,24 hours,48 hours & 72 hours